Close Menu

Microsoft

In Print

Premium

Bioinformatics Tool-Related Papers of Note, February 2009

People Transfer

Premium

Fate Therapeutics names Dan Shoemaker as CTO

Speakers at the Future of Genomic Medicine conference tempered their enthusiasm about the field by highlighting a number of obstacles standing in the way of making whole-genome studies a standard part of medical care.

Linguamatics plans this year to continue building a customer base among large pharmaceutical firms, while Bioalma is eyeing the academic market to help drive growth in 2009.

People Transfer

Premium

Thomas Fekete to direct Johns Hopkins' INBT; UW TechTransfer names Entrepreneur Residents and Advisors

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

Both companies are offering users of second-generation sequencing systems new tools to select portions of the genome for targeted resequencing but have optimized their products for different sequencing platforms.

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

In the wake of the announcement that the working draft of the human genome sequence is done, BioInform spoke with four informatics

Pages

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.